Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi.
Journal article
Gordon SB. et al, (2023), Wellcome Open Res, 8
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Journal article
Satti I. et al, (2022), Nature Communications, 13
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Journal article
Williams E. et al, (2022), Vaccine, 40, 3484 - 3489
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Journal article
Wilkie M. et al, (2022), Scientific reports, 12
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Journal article
Dockrell HM. and McShane H., (2022), EBioMedicine, 79
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
Journal article
Killingley B. et al, (2022), Nat Med
Challenges in Developing a Controlled Human Tuberculosis Challenge Model.
Journal article
Jackson S. and McShane H., (2022), Curr Top Microbiol Immunol
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Journal article
Fisher BA. et al, (2022), The Lancet Respiratory Medicine, 10, 255 - 266
Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre.
Journal article
Henderson LR. et al, (2022), Health research policy and systems, 20
“It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome
Journal article
Brown P. et al, (2022), Human Vaccines & Immunotherapeutics, 1 - 8
A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study
Journal article
Kiparoglou V. et al, (2021), Journal of Translational Medicine, 19
Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.
Journal article
Burel JG. et al, (2021), Tuberculosis (Edinburgh, Scotland), 131
Lessons from the pandemic on the value of research infrastructure
Journal article
Roope LSJ. et al, (2021), Health Research Policy and Systems, 19
SARS-CoV-2 Human Challenge Studies. Reply.
Journal article
Rapeport G. et al, (2021), The New England journal of medicine, 385
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
Journal article
Rapeport G. et al, (2021), The New England journal of medicine, 385, 961 - 964
Injection fears and COVID-19 vaccine hesitancy
Journal article
Freeman D. et al, (2021), Psychological Medicine, 1 - 11
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.
Journal article
Sibley L. et al, (2021), Scientific reports, 11
Equity for excellence in academic institutions: a manifesto for change
Journal article
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial
Journal article
Freeman D. et al, (2021), The Lancet Public Health, 6, e416 - e427
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
Journal article
Riste M. et al, (2021), Vaccines, 9